File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3201/eid2801.211099
- Scopus: eid_2-s2.0-85121681571
- PMID: 34932446
- WOS: WOS:000746318000008
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong
Title | Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong |
---|---|
Authors | |
Keywords | 2019 novel coronavirus disease COVID-19 Hong Kong SARS-CoV-2 coronavirus disease |
Issue Date | 2022 |
Publisher | US Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm |
Citation | Emerging Infectious Diseases, 2022, v. 28 n. 1, p. 62-68 How to Cite? |
Abstract | To determine the effects of nonpharmaceutical interventions (NPIs) for coronavirus disease on pediatric hospitalizations for infection with respiratory viruses other than severe acute respiratory syndrome coronavirus 2, we analyzed hospital data for 2017–2021. Compared with 2017–2019, age-specific hospitalization rates associated with respiratory viruses greatly decreased in 2020, when NPIs were in place. Also when NPIs were in place, rates of hospitalization decreased among children of all ages for infection with influenza A and B viruses, respiratory syncytial virus, adenovirus, parainfluenza viruses, human metapneumovirus, and rhinovirus/enterovirus. Regression models adjusted for age and seasonality indicated that hospitalization rates for acute febrile illness/respiratory symptoms of any cause were reduced by 76% and by 85%–99% for hospitalization for infection with these viruses. NPIs in Hong Kong were clearly associated with reduced pediatric hospitalizations for respiratory viruses; implementing NPIs and reopening schools were associated with only a small increase in hospitalizations for rhinovirus/enterovirus infections. |
Persistent Identifier | http://hdl.handle.net/10722/309896 |
ISSN | 2023 Impact Factor: 7.2 2023 SCImago Journal Rankings: 2.117 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chiu, SS | - |
dc.contributor.author | Cowling, BJ | - |
dc.contributor.author | Peiris, JSM | - |
dc.contributor.author | Chan, ELY | - |
dc.contributor.author | Wong, WHS | - |
dc.contributor.author | Lee, KP | - |
dc.date.accessioned | 2022-01-10T09:15:26Z | - |
dc.date.available | 2022-01-10T09:15:26Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Emerging Infectious Diseases, 2022, v. 28 n. 1, p. 62-68 | - |
dc.identifier.issn | 1080-6040 | - |
dc.identifier.uri | http://hdl.handle.net/10722/309896 | - |
dc.description.abstract | To determine the effects of nonpharmaceutical interventions (NPIs) for coronavirus disease on pediatric hospitalizations for infection with respiratory viruses other than severe acute respiratory syndrome coronavirus 2, we analyzed hospital data for 2017–2021. Compared with 2017–2019, age-specific hospitalization rates associated with respiratory viruses greatly decreased in 2020, when NPIs were in place. Also when NPIs were in place, rates of hospitalization decreased among children of all ages for infection with influenza A and B viruses, respiratory syncytial virus, adenovirus, parainfluenza viruses, human metapneumovirus, and rhinovirus/enterovirus. Regression models adjusted for age and seasonality indicated that hospitalization rates for acute febrile illness/respiratory symptoms of any cause were reduced by 76% and by 85%–99% for hospitalization for infection with these viruses. NPIs in Hong Kong were clearly associated with reduced pediatric hospitalizations for respiratory viruses; implementing NPIs and reopening schools were associated with only a small increase in hospitalizations for rhinovirus/enterovirus infections. | - |
dc.language | eng | - |
dc.publisher | US Department of Health and Human Services, Centers for Disease Control and Prevention. The Journal's web site is located at http://www.cdc.gov/ncidod/EID/index.htm | - |
dc.relation.ispartof | Emerging Infectious Diseases | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | 2019 novel coronavirus disease | - |
dc.subject | COVID-19 | - |
dc.subject | Hong Kong | - |
dc.subject | SARS-CoV-2 | - |
dc.subject | coronavirus disease | - |
dc.title | Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong | - |
dc.type | Article | - |
dc.identifier.email | Chiu, SS: ssschiu@hku.hk | - |
dc.identifier.email | Cowling, BJ: bcowling@hku.hk | - |
dc.identifier.email | Peiris, JSM: malik@hkucc.hku.hk | - |
dc.identifier.email | Chan, ELY: laiyin@hkucc.hku.hk | - |
dc.identifier.email | Wong, WHS: whswong@hku.hk | - |
dc.identifier.email | Lee, KP: lee1965@hkucc.hku.hk | - |
dc.identifier.authority | Chiu, SS=rp00421 | - |
dc.identifier.authority | Cowling, BJ=rp01326 | - |
dc.identifier.authority | Peiris, JSM=rp00410 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3201/eid2801.211099 | - |
dc.identifier.pmid | 34932446 | - |
dc.identifier.pmcid | PMC8714236 | - |
dc.identifier.scopus | eid_2-s2.0-85121681571 | - |
dc.identifier.hkuros | 331362 | - |
dc.identifier.volume | 28 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 62 | - |
dc.identifier.epage | 68 | - |
dc.identifier.isi | WOS:000746318000008 | - |
dc.publisher.place | United States | - |